Medicine and Dentistry
Neoplasm
100%
Magnetic Resonance Imaging
53%
Odds Ratio
41%
Computer Assisted Tomography
41%
Breast Cancer
40%
Hepatocellular Carcinoma
40%
Recurrent Disease
39%
Hazard Ratio
37%
Overall Survival
36%
Prevalence
34%
Cohort Analysis
31%
Prognostic Factor
28%
Apoplexy
25%
Meta-Analysis
22%
Randomized Controlled Trial
22%
Survival Rate
21%
Metastatic Carcinoma
20%
Body Mass Index
19%
Lung
19%
Biopsy Technique
19%
Retrospective Study
18%
Prostate Cancer
18%
Bleeding
18%
Colorectal Carcinoma
17%
Echography
16%
Lung Cancer
16%
Non Small Cell Lung Cancer
15%
Observational Study
15%
Logistic Regression Analysis
15%
Diabetes
15%
Diabetes Mellitus
14%
Progression Free Survival
14%
Liver Transplantation
14%
Clinical Feature
14%
Biological Marker
13%
Chronic Kidney Disease
13%
Lymph Node Metastasis
13%
In Vitro
13%
Lymph Node
13%
Gastrectomy
12%
COVID-19
12%
Cross Sectional Study
12%
Brain Ischemia
12%
Proportional Hazards Model
12%
Retrospective Cohort Study
12%
Stenosis
12%
Diagnostic Performance
11%
Hepatectomy
11%
Medical Record
11%
Coronary Artery Disease
11%
Cardiovascular System
11%
Atrial Fibrillation
11%
Health Care Cost
11%
Positron Emission Tomography
11%
Clear Cell Renal Cell Carcinoma
11%
Maturity Onset Diabetes of the Young
10%
Arm
10%
Pediatrics Patient
10%
Disease Free Survival
10%
Percutaneous Coronary Intervention
10%
Cervical Cancer
10%
Positron Emission Tomography-Computed Tomography
10%
Adenocarcinoma
10%
Aneurysm
10%
Prospective Study
10%
Cancer Cell
9%
Helicobacter Pylori
9%
Neck
9%
Out of Hospital Cardiac Arrest
9%
Magnetic Resonance Imaging
9%
Combination Therapy
9%
Myocardial Infarction
9%
Epidermal Growth Factor Receptor
9%
Immunohistochemistry
9%
Mortality Rate
9%
Laparoscopic Surgery
9%
Morphology
9%
Multidetector Computed Tomography
9%
Living Donor
8%
Placebo
8%
Ovarian Cancer
8%
Propensity Score Matching
8%
Diagnostic Accuracy
8%
Kidney Function
8%
Programmed Cell Death
8%
Fluorodeoxyglucose F 18
8%
Differential Diagnosis
8%
Comorbidity
8%
Prostatectomy
8%
Prospective Cohort Study
8%
Cholangiocarcinoma
8%
Postoperative Complication
8%
Computed Tomography Angiography
8%
Metabolic Syndrome
8%
Drug-Eluting Stent
8%
Pelvis
7%
Total Knee Arthroplasty
7%
Congestive Heart Failure
7%
Blood Pressure
7%
Nonalcoholic Fatty Liver
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
49%
Cohort Study
28%
Overall Survival
26%
Prevalence
25%
Liver Cell Carcinoma
21%
Recurrent Disease
21%
Breast Cancer
19%
Pharmacokinetics
19%
Placebo
16%
Progression Free Survival
15%
Non Small Cell Lung Cancer
14%
Lung Cancer
13%
Cerebrovascular Accident
13%
Randomized Controlled Trial
13%
Diabetes Mellitus
12%
Inflammation
12%
Non Insulin Dependent Diabetes Mellitus
11%
Combination Therapy
11%
Survival Rate
11%
Chronic Kidney Failure
11%
Normal Human
11%
Biological Marker
10%
Epidermal Growth Factor Receptor
10%
Heart Infarction
10%
Helicobacter Pylori
10%
Colorectal Carcinoma
10%
All Cause Mortality
9%
Retrospective Study
9%
Brain Ischemia
9%
Observational Study
9%
Asthma
9%
Prostate Cancer
9%
Atrial Fibrillation
8%
Receptor
8%
Tolerability
8%
Monotherapy
8%
Bleeding
8%
Coronary Artery Disease
8%
Congestive Heart Failure
7%
Messenger RNA
7%
Comorbidity
7%
Cytokine
7%
Acute Heart Infarction
7%
Cisplatin
7%
Paclitaxel
7%
Leporidae
7%
Alzheimer's Disease
7%
Hepatitis B Virus
6%
Metabolic Syndrome X
6%
Coronavirinae
6%
Parkinson's Disease
6%
Antiplatelet
6%
Clinical Feature
6%
Mouse Model
6%
Tumor Necrosis Factor
6%
Vasculotropin
6%
Inflammatory Arthritis
6%
Rheumatoid Arthritis
6%
Chronic Obstructive Lung Disease
6%
Disease Free Survival
6%
Carcinogenesis
6%
Prospective Study
6%
Remission
6%
Creatinine
5%
Mortality Rate
5%
Uterine Cervix Cancer
5%
Protein P53
5%
Statin (Protein)
5%
Pharmacodynamics
5%
Adenocarcinoma
5%
Acetylsalicylic Acid
5%
Polyethylene Terephthalate
5%
Nonalcoholic Fatty Liver
5%
Lymph Node Metastasis
5%
C Reactive Protein
5%
Disease Exacerbation
5%
Reactive Oxygen Metabolite
5%
Glioblastoma
5%
Out of Hospital Cardiac Arrest
5%
Metformin
5%
Chronic Hepatitis B
5%
Acute Kidney Failure
5%
Tumor Growth
5%
Gamma Urogastrone
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
21%
Prevalence
17%
Genotyping
16%
Overall Survival
14%
Cohort Study
14%
Single-Nucleotide Polymorphism
14%
Allele
14%
Programmed Cell Death
14%
Body Mass
12%
Epidermal Growth Factor Receptor
10%
Promoter Region
10%
Stem Cell
10%
Methylation
9%
Genome-Wide Association Study
9%
Carcinogenesis
8%
Blood Plasma
8%
Messenger RNA
7%
Magnetic Resonance Imaging
7%
Blood Pressure
7%
Survival Rate
6%
P53
6%
Genetic Polymorphism
6%
Kinase
6%
Phosphotransferase
6%
Enzyme
6%
Case-Control Study
6%
Gene Mutation
5%
Hepatitis B Virus
5%
Bone Density
5%
Single Nucleotide Polymorphism
5%
MicroRNA
5%
Haplotype
5%
Exon
5%
Gene Polymorphism
5%
down Regulation
5%
T Cell
5%
DNA Methylation
5%
All Cause Mortality
5%
Cardiac Arrest
5%